Home › Funds › Point72 Asset Management › BMRN
Point72 Asset Management position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
Latest position (Q1 2026)1.30M sh
Reported value held$73.39M
Portfolio Weight0.10%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 791.79K | $61.20M | New |
| Q4 2021 | 821.80K | $72.61M | Add |
| Q1 2022 | 451.74K | $34.83M | Reduce |
| Q2 2022 | 147.87K | $12.25M | Reduce |
| Q3 2022 | 595.40K | $50.47M | Add |
| Q4 2022 | 716.70K | $74.17M | Add |
| Q4 2023 | 455.30K | $43.90M | New |
| Q1 2024 | 1.35M | $117.54M | Add |
| Q3 2024 | 497.72K | $34.98M | New |
| Q4 2024 | 566.44K | $37.23M | Add |
| Q1 2025 | 395.75K | $27.98M | Reduce |
| Q4 2025 | 438.82K | $26.08M | New |
| Q1 2026 | 1.30M | $73.39M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BMRN
- Vanguard Group 18.13M sh · $1.08B · Q4 2025
- Dodge & Cox 14.84M sh · $849.43M · Q2 2026
- Norges Bank Investment Management 8.21M sh · $469.66M · Q2 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- AQR Capital Management 5.70M sh · $322.54M · Q2 2026
- Fidelity Management & Research (FMR) 4.82M sh · $275.97M · Q2 2026
- Geode Capital Management 3.91M sh · $223.89M · Q2 2026
- Capital Research Global Investors 3.50M sh · $200.52M · Q2 2026
- Millennium Management 2.11M sh · $120.95M · Q2 2026
- Charles Schwab Investment Management 1.62M sh · $92.47M · Q2 2026
- Northern Trust Corp 1.56M sh · $89.15M · Q2 2026
- Citadel Advisors 1.40M sh · $80.28M · Q2 2026